Home›Companies›Biotech & Pharma›Florey Biosciences

Florey Biosciences, Inc.

Updated Oct 27, 2026·Latest SEC filing Apr 29, 2025·Suggest an edit

About Florey Biosciences

Florey Biosciences is a private company based in Cambridge, Massachusetts, incorporated in 2024 in Delaware. It has reported $1,400,000 raised in one offering on Form D since April 2025. Its chief executive is Andres Cubillos Ruiz.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Apr 10, 2025Apr 29, 2025$1,400,000of $4.4M target1$1.4MEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Florey Biosciences's Form D filed Apr 29, 2025.

PH
Peter Hutt
Director
RG
Raphael Gayet
Executive officer
MS
Mark Smith
Director
AR
Andres Cubillos Ruiz
Chief Executive Officer and director

Sources

  1. SECFlorey Biosciences, Inc. filing history